Ian McKinnon

Bio:

Attempts are being made to embed AI across pharma launches, but how it actually enables better decisions is often unclear. This session illustrates concrete examples.

You'll see how AI turns fragmented launch data into validated, decision-ready intelligence across the launch lifecycle—integrating social, claims, advisory, publications, and field data to surface patient needs, identify the right experts, and connect insights directly to launch decisions.

The real competitive advantage isn't more dashboards or summaries. It's deep insights at decision velocity. AI moves fast—and exposes teams that don’t. This approach enables Medical Affairs teams to act earlier, with confidence, while there's still time to influence evidence strategy and scientific narrative.